THE EFFECT OF SULFINPYRAZONE (ANTURAN) ON PLATELET ECONOMY AND BLOOD COAGULATION IN MAN.
- 10 April 1965
- journal article
- Vol. 92 (15), 818-21
Abstract
Sulfinpyrazone (Anturan) administered in therapeutic doses over a period of several weeks produced prolongation of platelet survival and reduced turnover but with little change in blood coagulation. The changes in platelet survival and turnover were associated with reduced platelet adhesiveness. It is therefore possible to affect platelet economy in man significantly, without producing corresponding effects on blood coagulation.Keywords
This publication has 9 references indexed in Scilit:
- Blood Platelet Economy during Moderate and Intensive Heparin TherapyBlood, 1963
- BLOOD COAGULATION AND PLATELET ECONOMY IN SUBJECTS WITH PRIMARY GOUT1963
- [New observations on the correlations between hyperuricemic diathesis and arterial pathology: the place of uric acid eliminator medications in the treatment of arteriopathies of the extremities].1962
- Effect of Different Dietary Fats on Blood Coagulation, Platelet Economy, and Blood LipidsBMJ, 1962
- PLATELET ECONOMY DURING MODERATE AND INTENSIVE DICOUMAROL THERAPYThe Lancet, 1961
- ThrombosisJournal of Atherosclerosis Research, 1961
- Dicumarol TherapyCirculation Research, 1960
- Relationship between pKa and Uricosuric Activity in Phenylbutazone AnaloguesNature, 1958
- DETERMINATION OF THE LIFE SPAN OF HUMAN BLOOD PLATELETS USING LABELLED DIISOPROPYLFLUOROPHOSPHONATEJCI Insight, 1956